Biolase Stock Market Capitalization
| BIOL Stock | USD 0.15 0.01 7.14% |
BIOLASE fundamentals help investors to digest information that contributes to BIOLASE's financial success or failures. It also enables traders to predict the movement of BIOLASE Stock. The fundamental analysis module provides a way to measure BIOLASE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIOLASE stock.
| Last Reported | Projected for Next Year | ||
| Market Cap | 1.3 M | 1.2 M |
BIOLASE | Market Capitalization |
BIOLASE Company Market Capitalization Analysis
BIOLASE's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current BIOLASE Market Capitalization | 5.04 M |
Most of BIOLASE's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIOLASE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BIOLASE Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for BIOLASE is extremely important. It helps to project a fair market value of BIOLASE Stock properly, considering its historical fundamentals such as Market Capitalization. Since BIOLASE's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BIOLASE's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BIOLASE's interrelated accounts and indicators.
Click cells to compare fundamentals
BIOLASE Market Capitalization Historical Pattern
Today, most investors in BIOLASE Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BIOLASE's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's market capitalization growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BIOLASE market capitalization as a starting point in their analysis.
BIOLASE Market Capitalization |
| Timeline |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
BIOLASE Long Term Debt To Capitalization
Long Term Debt To Capitalization |
|
Based on the recorded statements, the market capitalization of BIOLASE is about 5.04 M. This is 99.96% lower than that of the Health Care Equipment & Supplies sector and 99.95% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.97% higher than that of the company.
BIOLASE Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIOLASE's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIOLASE could also be used in its relative valuation, which is a method of valuing BIOLASE by comparing valuation metrics of similar companies.BIOLASE is currently under evaluation in market capitalization category among related companies.
BIOLASE Fundamentals
| Return On Equity | -6.03 | ||||
| Return On Asset | -0.29 | ||||
| Profit Margin | (0.42) % | ||||
| Operating Margin | (0.35) % | ||||
| Current Valuation | 16.27 M | ||||
| Shares Outstanding | 33.26 M | ||||
| Shares Owned By Insiders | 0.32 % | ||||
| Shares Owned By Institutions | 8.01 % | ||||
| Number Of Shares Shorted | 592.68 K | ||||
| Price To Earning | (7.23) X | ||||
| Price To Book | 0.77 X | ||||
| Price To Sales | 0.1 X | ||||
| Revenue | 49.16 M | ||||
| Gross Profit | 16.53 M | ||||
| EBITDA | (15.14 M) | ||||
| Net Income | (20.63 M) | ||||
| Cash And Equivalents | 9.96 M | ||||
| Cash Per Share | 1.39 X | ||||
| Total Debt | 17.91 M | ||||
| Debt To Equity | 1.07 % | ||||
| Current Ratio | 2.46 X | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (14.09 M) | ||||
| Short Ratio | 0.06 X | ||||
| Earnings Per Share | (29.44) X | ||||
| Price To Earnings To Growth | (0.22) X | ||||
| Target Price | 11.22 | ||||
| Number Of Employees | 157 | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 5.04 M | ||||
| Total Asset | 35.1 M | ||||
| Retained Earnings | (316.8 M) | ||||
| Working Capital | 5.2 M | ||||
| Current Asset | 34.8 M | ||||
| Current Liabilities | 15.11 M | ||||
| Net Asset | 35.1 M |
About BIOLASE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIOLASE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIOLASE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIOLASE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BIOLASE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIOLASE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIOLASE will appreciate offsetting losses from the drop in the long position's value.Moving together with BIOLASE Stock
| 0.62 | AHG | Akso Health Group | PairCorr |
Moving against BIOLASE Stock
| 0.68 | TLIS | Talis Biomedical Corp | PairCorr |
| 0.62 | TNDM | Tandem Diabetes Care | PairCorr |
| 0.58 | SNDA | Sonida Senior Living | PairCorr |
| 0.52 | DHR | Danaher Earnings Call This Week | PairCorr |
| 0.49 | JYNT | Joint Corp Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to BIOLASE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BIOLASE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BIOLASE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BIOLASE to buy it.
The correlation of BIOLASE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BIOLASE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BIOLASE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BIOLASE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out BIOLASE Piotroski F Score and BIOLASE Altman Z Score analysis. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for BIOLASE Stock analysis
When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.44) | Revenue Per Share 38.469 | Quarterly Revenue Growth (0.04) | Return On Assets (0.29) | Return On Equity (6.03) |
The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.